Evidence map›Paper›PMID 37643974›Full record

ReviewZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2023

Clinical prospects and research strategies of long non-coding RNA encoding micropeptides.

Xinyi Wang, Zhen Zhang, Chengyu Shi, Ying Wang, Tianhua Zhou, Aifu Lin

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. The hidden players: LncRNA-Encoded micropeptides in cancer hallmarks.Cellular and molecular life sciences : CMLS · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xinyi WangCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China. 22207016@zju.edu.cn.
Zhen ZhangCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Chengyu ShiCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Ying WangCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Tianhua ZhouZhejiang University Cancer Center, Hangzhou 310058, China. tzhou@zju.edu.cn.
Aifu LinCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China. linaifu@zju.edu.cn.
Zhejiang Cancer Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) which are usually thought to have no protein coding ability, are widely involved in cell proliferation, signal transduction and other biological activities. However, recent studies have suggested that short open reading frames (sORFs) of some lncRNAs can encode small functional peptides (micropeptides). These micropeptides appear to play important roles in calcium homeostasis, embryonic development and tumorigenesis, suggesting their potential as therapeutic targets and diagnostic biomarkers. Currently, bioinformatic tools as well as experimental methods such as ribosome mapping and

Indexed as

RNA, Long NoncodingAntibodiesCarcinogenesisFemaleHumansMicropeptidesPregnancyResearch DesignAntibodiesMicropeptidesRNA, Long NoncodingLong non-coding RNAMass spectrometryMicropeptideReviewRibosome profilingShort open reading frame

Identifiers

PMID37643974
PMCPMC10495248
OpenAlexW4385702777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.